Skip to content
Stock screener

PETS Petmed Express Inc stock chart & analysis

Conviction 49Consumer StaplesScan · Tue, Nov 17, 2026

Petmed Express Inc (PETS) closed at $0.8935 (-0.47%) on Nov 17, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 19, RS Rating 12, -78.2% from its 52-week high, -72.1% year to date. Sector: Consumer Staples · Retail-Drug Stores and Proprietary Stores.

PETS$0.8935-0.47%
ResistanceSupportVol 14Insider buy
Loading chart…

Why PETS moved

From the StockSetups movers recaps that covered PETS, newest first. A recap states what was known that day.

Petmed Express IncRetail-Drug Stores and Proprietary Storeswww.petmeds.com ↗
Price0.8935
Change-0.47%
Gap-3.06%
Rel volume1.00×
Avg volume125.35K
Avg $ vol135.97K
SMA 201.14
SMA 501.31
SMA 2001.98
Price vs 50-31.99%
Price vs 200-54.93%
MA stackbearish
50/200 cross—
Supertrenddown · 1.09
RSI (14)19
MACD hist-0.02
MACD crossbear · 3d
Stoch %K / %D10 / 8
ADX (14)42
+DI / −DI10 / 43
RSI divergence—
MACD divergence—
ATR %7.24%
ADR %5.56%
52w high4.10
52w low0.8500
From 52w high-78.21%
Above 52w low+5.12%
New 52w highNo
SqueezeOff
Bollinger width39.74%
%B-0.05
Donchian pos10.00%
Donchian high1.29
Donchian low0.8500
AVWAP (52w high)2.39
vs AVWAP high-62.61%
AVWAP (52w low)0.8953
vs AVWAP low-0.20%
OBV trendDown
Chaikin MF (20)-0.28
Today vs 20d1.00×
Avg vol (14d)141.18K
Avg vol (20d)125.35K
Avg $ vol (20d)135.97K
Market cap19.86M
RS Rating12 / 99
RS 3m (vs SPY)-44.76%
RS 6m (vs SPY)-59.39%
RS line new highNo
Trend template0/8
Technical rank9.9
1 week-26.16%
1 month-22.30%
3 months-49.52%
6 months-59.57%
1 year-55.33%
YTD-72.08%
P/E-0.35
P/B1.18
P/S0.11
P/FCF-0.60
EPS-2.74
Div yield0.11%
ROE-339.73%
ROA-96.44%
Debt/Eq—
Current0.60
EV/EBITDA-0.17
Gross margin28.05%
Net margin-32.00%
Rev growth-21.13%
EPS growth-813.51%
Price target—
Target upside—
Analyst rating—
Institutional21.21%
Ent. value8.45M
Revenue35.77M
Net income-6.43M
Gross profit9.8M
Free cash flow-33.01M
IndustryRetail-Drug Stores and Proprietary Stores
ExchangeNasdaq
Shares out21.37M
Employees189
ListedWed, Sep 17, 1997
Free float17.87M
Float %83.5%
Short interest—
Days to cover—
Short volume63.6%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction49 / 100
Pattern quality—
Tech rank9.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.29
Support1.15
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

PETS technical analysis

Trend

PETS is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 32.0% below the 50-day ($1.31) and 54.9% below the 200-day ($1.98). ADX(14) at 42 points to a strong, established trend. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 19, in oversold territory. MACD crossed below its signal line 3 sessions ago. Its RS Rating of 12 puts its weighted 12-month performance ahead of about 12% of the US market.

Volume and volatility

Volume on the latest session ran 1.0× its 20-day average. It trades about $135,967 a day on average. ATR(14) is $0.0647, 7.2% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.28) shows distribution.

Key levels

The chart pattern's support is $1.15 and its resistance $1.29. The 52-week range is $0.8500 to $4.10; price is 78.2% below the high and 5.1% above the low. The VWAP anchored at the 52-week high is $2.39, above price.

Performance

PETS returned -26.2% (1 week), -22.3% (1 month), -49.5% (3 months), -59.6% (6 months), -55.3% (1 year), -72.1% (year to date).

About Petmed Express Inc

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Retail-Drug Stores and Proprietary Stores · Listed 1997 · 189 employees

Insider activity

SEC Form 4 transactions in PETS · open-market 1 buy

InsiderSideShares
KRULIK DOUGLAS
CAO and Interim CFO · Common Stock · 2026-10-30
Tax2.44K
KRULIK DOUGLAS
CAO and Interim CFO · Common Stock · 2026-09-27
Tax3.25K
KRULIK DOUGLAS
CAO and Interim CFO · Common Stock · 2026-03-09
Tax2.96K
KRULIK DOUGLAS
CAO and Interim CFO · Common Stock · 2025-09-27
Tax3.25K
Elkeles Tamar
Director · Common Stock · 2026-09-17
Grant49.92K
Campbell Leslie C.G.
Interim CEO and President · Common Stock · 2026-08-11
Grant60K
Batushansky Peter
Director · Common Stock · 2026-08-11
Grant55.55K
LaCamp James
Director · Common Stock · 2026-08-11
Grant55.55K
Mennen Justin L.
Director · Common Stock · 2026-08-11
Grant55.55K
NINA CAPITAL HOLDINGS INC.
10% owner · Common Stock · 2026-06-08
Buy25K

SEC filings

EDGAR filings in PETS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.